PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Friday, February 13
    Trending
    • Praveg’s Q3 FY26 Standalone Total Income Up 69.46 Percent and Consolidated Total Income up 65.29 Percent
    • DAR CREDIT & CAPITAL LIMITED POSTS POWERFUL Q3 FY26 RESULTS
    • Paradigm Realty Elevates High-Rise Living in Mumbai with the Unveiling of an Ultra-Luxury Double-Height Lobby at Anantaara in Borivali West
    • India’s Trusted Labour Law Compliance Partner for 20 Years – Digiliance
    • Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2025
    • New Research Highlights ‘Biofilm Shield’ as the Hidden Culprit Behind Recurrent UTIs
    • Sanatan Premier League Gets Strong Response Across the Country, Huge Crowd Seen in Delhi
    • Budget 2025–26 Signals Strong Push for Manufacturing, MSMEs and Inclusive Growth: All India Manufacturer’s Organisation National President Rajiv Ranjan
    Submit News
    PNN DigitalPNN Digital
    pnn
    • Home
    • Editor’s Pick
    • Business
    • Entertainment
    • National
    • Lifestyle
    • Technology
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»Business News

    Upto 90% Savings for 75 Lakh+ Customers through Davaindia

    Vishal JasaniVishal JasaniUpdated:01/07/2023 Business News 3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Surat (Gujarat) [India], July 1: Davaindia Generic Pharmacy, the leading private generic pharmacy retail chain, a brand of Zota Healthcare Ltd., has successfully provided up to 90% Savings to 75 lakh+ customers who purchase generic medicines from their stores.

    Davaindia’s commitment to offering affordable, high-quality generic medicines has revolutionized the Indian healthcare landscape, making essential medications via a range of 2200+ generic medicines accessible to the masses.

    Davaindia has become synonymous as cost-effective healthcare solutions, providing customers with not only a comparative cost benefit but also a vast repertoire of medicines & OTC products. Since its inception in 2017, Davaindia has rapidly expanded its presence, establishing more than 600+ retail outlets across the country and serving a vast customer base of over 75 lakh individuals. Davaindia also has given wings to entrepreneurship dreams of 500+ ambitious individuals via it’s robust franchisee network.

    The savings offered by Davaindia reflect the company’s dedication to ensuring affordable healthcare to the last mile of the country. By promoting the use of generic medicines, which are the equivalent to their branded counterparts but also available at significantly lower prices, Davaindia has empowered customers to make informed choices that benefit their health and finances.

    Zota Healthcare Ltd., the parent company of Davaindia, is renowned for its diverse range of pharmaceutical, nutraceutical, and ayurvedic products. Established in 2000, Zota Healthcare has emerged as a distinguished pharma company, listed on the NSE (National Stock Exchange). The company’s commitment to innovation, quality, and integrity has propelled its growth, allowing it to serve both regulated and semi-regulated markets in Asia, Africa, Russia, and Latin America.

    Commenting on this Dr. Sujit Paul the Group CEO – Zota Healthcare Ltd.said, “The success of Davaindia and Zota Healthcare can be attributed to their unwavering focus on providing affordable healthcare solutions without compromising on quality. By prioritizing customer welfare and ensuring accessibility to essential medicines, the companies have positively impacted the lives of millions of individuals across India.”

    Davaindia is committed to its aim of making affordable healthcare a reality for every Indian as well as individuals across the globe as it continues to develop its network of retail shops and reach a broader audience. Both Zota Healthcare Ltd. and Davaindia Generic Pharmacy, by their dedication to quality, are changing the face of the pharmaceutical industry and offering new hope to patients in search of low-cost, effective treatments under a single roof.

    If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Vishal Jasani

    Keep Reading

    Bright Gujarati Entertainment Awards 2025 Ignite Talent & Business Brilliance

    Airfloa Rail Crosses INR 113 Crore in New Orders Within a Week; Order Book Nears INR 455 Crore

    Vishwa Sindhi Hindu Foundation of Associations (VSHFA) to Hold Grand “Shashakt Samaj” at Vigyan Bhawan, New Delhi

    AI Creativity Hacks: How to Turn Boring Content into Art in 10 Minutes

    Game Changers Texfab Hosts Successful Investor Roadshows Ahead of SME IPO

    Language and Learning Foundation and Tata Trusts Strengthen Foundational Learning Through Relationship-Driven Change in Shravasti

    pnn
    Recent Posts
    • Praveg’s Q3 FY26 Standalone Total Income Up 69.46 Percent and Consolidated Total Income up 65.29 Percent
    • DAR CREDIT & CAPITAL LIMITED POSTS POWERFUL Q3 FY26 RESULTS
    • Paradigm Realty Elevates High-Rise Living in Mumbai with the Unveiling of an Ultra-Luxury Double-Height Lobby at Anantaara in Borivali West
    • India’s Trusted Labour Law Compliance Partner for 20 Years – Digiliance
    • Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2025

    Praveg’s Q3 FY26 Standalone Total Income Up 69.46 Percent and Consolidated Total Income up 65.29 Percent

    13/02/2026

    DAR CREDIT & CAPITAL LIMITED POSTS POWERFUL Q3 FY26 RESULTS

    13/02/2026

    Paradigm Realty Elevates High-Rise Living in Mumbai with the Unveiling of an Ultra-Luxury Double-Height Lobby at Anantaara in Borivali West

    13/02/2026

    India’s Trusted Labour Law Compliance Partner for 20 Years – Digiliance

    12/02/2026

    Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter and Nine Months Ended December 31, 2025

    12/02/2026

    New Research Highlights ‘Biofilm Shield’ as the Hidden Culprit Behind Recurrent UTIs

    12/02/2026
    Facebook Instagram Twitter
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us
    • About Us
    © 2026 PNN Digital. Designed by Primex Media Services.

    Type above and press Enter to search. Press Esc to cancel.